Irinotecan-Eluting 75 –150-μm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I Study

The primary end point of this trial was to determine the feasibility and safety of transarterial chemoembolization with the use of 75 –150-μm drug-eluting embolics loaded with irinotecan (DEE-IRI) for the treatment of metastatic colorectal cancer (CRC) refractory to systemic chemotherapy.

Source: Journal of Vascular and Interventional Radiology : JVIR - October 15, 2018 Category: Radiology Authors: Arash Fereydooni, Brian Letzen, Mansur A. Ghani, Milena A. Miszczuk, Steffen Huber, Julius Chapiro, Todd Schlachter, Jean-Francois Geschwind, Christos Georgiades Tags: Clinical Study Source Type: research